Related Experiment Video
Updated: May 16, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
[Managing cutaneous toxicities of targeted therapies]
1Division of Dermatology, Shizuoka Cancer Center Hospital, Shizuoka 411-8777, Japan.
Abstract:
Molecularly targeted therapies have shown efficacy in many types of cancer, and the induction for their use is increasing rapidly. However, it is frequently associated with varied and unique cutaneous side effects, such as hand-foot-syndrome, rash, dry skin and paronychia. These effects, when severe or mild, tend to terminate the therapy because they inevitably impact the quality of life of patients. Treatment by emollients(steroids and moisturizing creams), topical antibiotics(MINO), topical corticosteroids, and antihistamines are accurately required at the early stages. Close interaction, among prescribers, dermatologists and nurses, is highly recommended in order to introduce preventative skin care(homeostasis)based on moisture retention, clean skin, and protection from agents. The side effects can be diagnosed and treated early by the multidisciplinary team. The balances between therapeutic benefit and cutaneous reaction should be considered, thus allowing for potentially greater success of anticancer therapy.
Insights
Molecularly targeted cancer therapies can cause skin side effects, impacting patient quality of life. Early intervention with skincare and multidisciplinary team collaboration is key to managing these reactions and ensuring treatment success.
Area of Science:
- Oncology and Dermatology
- Cancer Therapeutics
- Cutaneous Medicine
Context:
- Molecularly targeted therapies are increasingly used for cancer treatment.
- These therapies frequently cause unique cutaneous side effects like hand-foot syndrome, rash, dry skin, and paronychia.
- These side effects can significantly impair patients' quality of life and lead to treatment discontinuation.
Purpose:
- To highlight the common cutaneous side effects associated with molecularly targeted cancer therapies.
- To emphasize the importance of early diagnosis and management of these side effects.
- To advocate for a multidisciplinary approach involving oncologists, dermatologists, and nurses for preventative skincare and treatment.
Summary:
- Cutaneous side effects are a common challenge in molecularly targeted cancer therapy.
- Management strategies include emollients, topical antibiotics, corticosteroids, and antihistamines.
- Preventative skincare focusing on moisture retention, cleanliness, and protection is crucial.
Impact:
- Effective management of skin toxicities can improve patient quality of life.
- Proactive and collaborative care can prevent treatment termination, enhancing anticancer therapy success.
- This approach balances therapeutic benefits with the management of cutaneous reactions.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drug Toxicity: Dose-Dependent Reactions
